Magnetic resonance imaging (MRI) with a proton density fat fraction (PDFF) sequence is the most accurate, noninvasive method for assessing hepatic steatosis. However, manual measurement on the PDFF map is time-consuming. This study aimed to validate automated whole-liver fat quantification for assessing hepatic steatosis with MRI-PDFF. In this prospective study, 80 patients were enrolled from August 2020 to January 2023. Baseline MRI-PDFF and magnetic resonance spectroscopy (MRS) data were collected. The analysis of MRI-PDFF included values from automated whole-liver segmentation (autoPDFF) and the average value from measurements taken from eight segments (avePDFF). Twenty patients with ≥10% autoPDFF values who received 24 weeks of exercise training were also collected for the chronologic evaluation. The correlation and concordance coefficients (r and ρ) among the values and differences were calculated. There were strong correlations between autoPDFF versus avePDFF, autoPDFF versus MRS, and avePDFF versus MRS (r=0.963, r=0.955, and r=0.977, all p<0.001). The autoPDFF values were also highly concordant with the avePDFF and MRS values (ρ=0.941 and ρ=0.942). The autoPDFF, avePDFF, and MRS values consistently decreased after 24 weeks of exercise. The change in autoPDFF was also highly correlated with the changes in avePDFF and MRS (r=0.961 and r=0.870, all p<0.001). Automated whole-liver fat quantification might be feasible for clinical trials and practice, yielding values with high correlations and concordance with the time-consuming manual measurements from the PDFF map and the values from the highly complex processing of MRS (ClinicalTrials.gov identifier: NCT04463667).

Organ segmentation using ¹⁸F-FDG PET images alone has not been extensively explored. Segmentation based methods based on deep learning (DL) have traditionally relied on CT or MRI images, which are vulnerable to alignment issues and artifacts. This study aimed to develop a DL approach for segmenting the entire liver based solely on ¹⁸F-FDG PET images. We analyzed data from 120 patients who were assessed using ¹⁸F-FDG PET. A three-dimensional (3D) U-Net model from nnUNet and preprocessed PET images served as DL and input images, respectively, for the model. The model was trained with 5-fold cross-validation on data from 100 patients, and segmentation accuracy was evaluated on an independent test set of 20 patients. Accuracy was assessed using Intersection over Union (IoU), Dice coefficient, and liver volume. Image quality was evaluated using mean (SUVmean) and maximum (SUVmax) standardized uptake value and signal-to-noise ratio (SNR). The model achieved an average IoU of 0.89 and an average Dice coefficient of 0.94 based on test data from 20 patients, indicating high segmentation accuracy. No significant discrepancies in image quality metrics were identified compared with ground truth. Liver regions were accurately extracted from ¹⁸F-FDG PET images which allowed rapid and stable evaluation of liver uptake in individual patients without the need for CT or MRI assessments.

Interfraction variations during radiation therapy pose a challenge for patients with cervical cancer, highlighting the benefits of online adaptive radiation therapy (oART). However, adaptation decisions rely on subjective image reviews by physicians, leading to high interobserver variability and inefficiency. This study explores the feasibility of using artificial intelligence for decision-making in oART. A total of 24 patients with cervical cancer who underwent 671 fractions of daily fan-beam computed tomography (FBCT) guided oART were included in this study, with each fraction consisting of a daily FBCT image series and a pair of scheduled and adaptive plans. Dose deviations of scheduled plans exceeding predefined criteria were labeled as "trigger," otherwise as "nontrigger." A data set comprising 588 fractions from 21 patients was used for model development. For the machine learning model (ML), 101 morphologic, gray-level, and dosimetric features were extracted, with feature selection by the least absolute shrinkage and selection operator (LASSO) and classification by support vector machine (SVM). For deep learning, a Siamese network approach was used: the deep learning model of contour (DL_C) used only imaging data and contours, whereas a deep learning model of contour and dose (DL_D) also incorporated dosimetric data. A 5-fold cross-validation strategy was employed for model training and testing, and model performance was evaluated using the area under the curve (AUC), accuracy, precision, and recall. An independent data set comprising 83 fractions from 3 patients was used for model evaluation, with predictions compared against trigger labels assigned by 3 experienced radiation oncologists. Based on dosimetric labels, the 671 fractions were classified into 492 trigger and 179 nontrigger cases. The ML model selected 39 key features, primarily reflecting morphologic and gray-level changes in the clinical target volume (CTV) of the uterus (CTV_U), the CTV of the cervix, vagina, and parametrial tissues (CTV_C), and the small intestine. It achieved an AUC of 0.884, with accuracy, precision, and recall of 0.825, 0.824, and 0.827, respectively. The DL_C model demonstrated superior performance with an AUC of 0.917, accuracy of 0.869, precision of 0.860, and recall of 0.881. The DL_D model, which incorporated additional dosimetric data, exhibited a slight decline in performance compared with DL_C. Heatmap analyses indicated that for trigger fractions, the deep learning models focused on regions where the reference CT's CTV_U did not fully encompass the daily FBCT's CTV_U. Evaluation on an independent data set confirmed the robustness of all models. The weighted model's prediction accuracy significantly outperformed the physician consensus (0.855 vs 0.795), with comparable precision (0.917 vs 0.925) but substantially higher recall (0.887 vs 0.790). This study proposes machine learning and deep learning models to identify treatment fractions that may benefit from adaptive replanning in radical radiation therapy for cervical cancer, providing a promising decision-support tool to assist clinicians in determining when to trigger the oART workflow during treatment.

Survival of patients with high-risk hepatoblastoma remains low, and early identification of high-risk hepatoblastoma is critical. To investigate the clinical value of contrast-enhanced computed tomography (CECT) radiomics in predicting high-risk hepatoblastoma. Clinical and CECT imaging data were retrospectively collected from 162 children who were treated at our hospital and pathologically diagnosed with hepatoblastoma. Patients were categorized into high-risk and non-high-risk groups according to the Children's Hepatic Tumors International Collaboration - Hepatoblastoma Study (CHIC-HS). Subsequently, these cases were randomized into training and test groups in a ratio of 7:3. The region of interest (ROI) was first outlined in the pre-treatment venous images, and subsequently the best features were extracted and filtered, and the radiomics model was built by three machine learning methods: namely, Bagging Decision Tree (BDT), Logistic Regression (LR), and Stochastic Gradient Descent (SGD). The AUC, 95 % CI, and accuracy of the model were calculated, and the model performance was evaluated by the DeLong test. The AUCs of the Bagging decision tree model were 0.966 (95 % CI: 0.938-0.994) and 0.875 (95 % CI: 0.77-0.98) for the training and test sets, respectively, with accuracies of 0.841 and 0.816,respectively. The logistic regression model has AUCs of 0.901 (95 % CI: 0.839-0.963) and 0.845 (95 % CI: 0.721-0.968) for the training and test sets, with accuracies of 0.788 and 0.735, respectively. The stochastic gradient descent model has AUCs of 0.788 (95 % CI: 0.712 -0.863) and 0.742 (95 % CI: 0.627-0.857) with accuracies of 0.735 and 0.653, respectively. CECT-based imaging histology identifies high-risk hepatoblastomas and may provide additional imaging biomarkers for identifying high-risk hepatoblastomas.

Despite continued advances in oncology, cancer remains a leading cause of global mortality, highlighting the need for diagnostic and prognostic tools that are both accurate and interpretable. Unimodal approaches often fail to capture the biological and clinical complexity of tumors. In this study, we present a suite of task-specific AI models that leverage CT imaging, multi-omics profiles, and structured clinical data to address distinct challenges in segmentation, classification, and prognosis. We developed three independent models across large public datasets. Task 1 applied a 3D U-Net to segment pancreatic tumors from CT scans, achieving a Dice Similarity Coefficient (DSC) of 0.7062. Task 2 employed a hierarchical ensemble of omics-based classifiers to distinguish tumor from normal tissue and classify six major cancer types with 98.67% accuracy. Task 3 benchmarked classical machine learning models on clinical data for prognosis prediction across three cancers (LIHC, KIRC, STAD), achieving strong performance (e.g., C-index of 0.820 in KIRC, AUC of 0.978 in LIHC). Across all tasks, explainable AI methods such as SHAP and attention-based visualization enabled transparent interpretation of model outputs. These results demonstrate the value of tailored, modality-aware models and underscore the clinical potential of applying such tailored AI systems for precision oncology. Technical FoundationsO_LISegmentation (Task 1): A custom 3D U-Net was trained using the Task07_Pancreas dataset from the Medical Segmentation Decathlon (MSD). CT images were preprocessed with MONAI-based pipelines, resampled to (64, 96, 96) voxels, and intensity-windowed to HU ranges of -100 to 240. C_LIO_LIClassification (Task 2): Multi-omics data from TCGA--including gene expression, methylation, miRNA, CNV, and mutation profiles--were log-transformed and normalized. Five modality-specific LightGBM classifiers generated meta-features for a late-fusion ensemble. Stratified 5-fold cross-validation was used for evaluation. C_LIO_LIPrognosis (Task 3): Clinical variables from TCGA were curated and imputed (median/mode), with high-missing-rate columns removed. Survival models (e.g., Cox-PH, Random Forest, XGBoost) were trained with early stopping. No omics or imaging data were used in this task. C_LIO_LIInterpretability: SHAP values were computed for all tree-based models, and attention-based overlays were used in imaging tasks to visualize salient regions. C_LI

PSMA PET/CT imaging has been increasingly utilized in the management of patients with metastatic prostate cancer (mPCa). Imaging biomarkers derived from PSMA PET may provide improved prognostication and prediction of treatment response for mPCa patients. This study investigates a novel deep learning-derived imaging biomarker framework for outcome prediction using multi-modal PSMA PET/CT and clinical features. A single institution cohort of 99 mPCa patients with 396 lesions was evaluated. Imaging features were extracted from cropped lesion areas and combined with clinical variables including body mass index, ECOG performance status, prostate specific antigen (PSA) level, Gleason score, and treatments received. The PSA progression-free survival (PFS) model was trained using a ResNet architecture with a Cox proportional hazards loss function using five-fold cross-validation. Performance was assessed using concordance index (C-index) and Kaplan-Meier survival analysis. Among evaluated model architectures, the ResNet-18 backbone offered the best performance. The multi-modal deep learning framework achieved a 5-fold cross-validation C-index ranging from 0.75 to 0.94, outperforming models incorporating imaging only (0.70-0.89) and clinical features only (0.53-0.65). Kaplan-Meir survival analysis performed on the deep learning-derived predictions demonstrated clear risk stratification, with a median PSA progression free survival (PFS) of 19.7 months in the high-risk group and 26 months in the low-risk group (P < 0.001). Deep learning-derived imaging biomarker based on PSMA PET/CT can effectively predict PSA PFS for mPCa patients. Further clinical validation in prospective cohorts is warranted.

Artificial intelligence (AI) models based on pathological slides have great potential to assist pathologists in disease diagnosis and have become an important research direction in the field of medical image analysis. The aim of this study was to develop an AI model based on whole-slide images to predict the stage of colon cancer. In this study, a total of 100 pathological slides of colon cancer patients were collected as the training set, and 421 pathological slides of colon cancer were downloaded from The Cancer Genome Atlas (TCGA) database as the external validation set. Cellprofiler and CLAM tools were used to extract pathological features, and machine learning algorithms and deep learning algorithms were used to construct prediction models. The area under the curve (AUC) of the best machine learning model was 0.78 in the internal test set and 0.68 in the external test set. The AUC of the deep learning model in the internal test set was 0.889, and the accuracy of the model was 0.854. The AUC of the deep learning model in the external test set was 0.700. The prediction model has the potential to generalize in the process of combining pathological omics diagnosis. Compared with machine learning, deep learning has higher recognition and accuracy of images, and the performance of the model is better.

Accurately identifying difficult laparoscopic cholecystectomy (DLC) preoperatively remains a clinical challenge. Previous studies utilizing clinical variables or morphological imaging markers have demonstrated suboptimal predictive performance. This study aims to develop an optimal radiomics-clinical model by integrating preoperative CT-based radiomics features with clinical characteristics. A retrospective analysis was conducted on 2,055 patients who underwent laparoscopic cholecystectomy (LC) for cholecystitis at our center. Preoperative CT images were processed with super-resolution reconstruction to improve consistency, and high-throughput radiomic features were extracted from the gallbladder wall region. A combination of radiomic and clinical features was selected using the Boruta-LASSO algorithm. Predictive models were constructed using six machine learning algorithms and validated, with model performance evaluated based on the AUC, accuracy, Brier score, and DCA to identify the optimal model. Model interpretability was further enhanced using the SHAP method. The Boruta-LASSO algorithm identified 10 key radiomic and clinical features for model construction, including the Rad-Score, gallbladder wall thickness, fibrinogen, C-reactive protein, and low-density lipoprotein cholesterol. Among the six machine learning models developed, the radiomics-clinical model based on the random forest algorithm demonstrated the best predictive performance, with an AUC of 0.938 in the training cohort and 0.874 in the validation cohort. The Brier score, calibration curve, and DCA confirmed the superior predictive capability of this model, significantly outperforming previously published models. The SHAP analysis further visualized the importance of features, enhancing model interpretability. This study developed the first radiomics-clinical random forest model for the preoperative prediction of DLC by machine learning algorithms. This predictive model supports safer and individualized surgical planning and treatment strategies.

Objectives: Timely and accurate detection of colorectal polyps plays a crucial role in diagnosing and preventing colorectal cancer, a major cause of mortality worldwide. This study introduces a new, lightweight, and efficient framework for polyp detection that combines the Local Outlier Factor (LOF) algorithm for filtering noisy data with the YOLO-v11n deep learning model. Study design: An experimental study leveraging deep learning and outlier removal techniques across multiple public datasets. Methods: The proposed approach was tested on five diverse and publicly available datasets: CVC-ColonDB, CVC-ClinicDB, Kvasir-SEG, ETIS, and EndoScene. Since these datasets originally lacked bounding box annotations, we converted their segmentation masks into suitable detection labels. To enhance the robustness and generalizability of our model, we apply 5-fold cross-validation and remove anomalous samples using the LOF method configured with 30 neighbors and a contamination ratio of 5%. Cleaned data are then fed into YOLO-v11n, a fast and resource-efficient object detection architecture optimized for real-time applications. We train the model using a combination of modern augmentation strategies to improve detection accuracy under diverse conditions. Results: Our approach significantly improves polyp localization performance, achieving a precision of 95.83%, recall of 91.85%, F1-score of 93.48%, [email protected] of 96.48%, and [email protected]:0.95 of 77.75%. Compared to previous YOLO-based methods, our model demonstrates enhanced accuracy and efficiency. Conclusions: These results suggest that the proposed method is well-suited for real-time colonoscopy support in clinical settings. Overall, the study underscores how crucial data preprocessing and model efficiency are when designing effective AI systems for medical imaging.

This study aims to evaluate the effectiveness of a deep learning (DL)-enhanced four-fold parallel acquisition technique (P4) in improving prostate MR image quality while optimizing scan efficiency compared to the traditional two-fold parallel acquisition technique (P2). Patients undergoing prostate MRI with DL-enhanced acquisitions were analyzed from January 2024 to July 2024. The participants prospectively received T2-weighted sequences in all imaging planes using both P2 and P4. Three independent readers assessed image quality, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR). Significant differences in contrast and gray-level properties between P2 and P4 were identified through radiomics analysis (p <.05). A total of 51 participants (mean age 69.4 years ± 10.5 years) underwent P2 and P4 imaging. P4 demonstrated higher CNR and SNR values compared to P2 (p <.001). P4 was consistently rated superior to P2, demonstrating enhanced image quality and greater diagnostic precision across all evaluated categories (p <.001). Furthermore, radiomics analysis confirmed that P4 significantly altered structural and textural differentiation in comparison to P2. The P4 protocol reduced T2w scan times by 50.8%, from 11:48 min to 5:48 min (p <.001). In conclusion, P4 imaging enhances diagnostic quality and reduces scan times, improving workflow efficiency, and potentially contributing to a more patient-centered and sustainable radiology practice.